Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Primary Prophylaxis for Prevention of TB in Prison's Populations
NCT03028129Phase 4Terminated
- Sponsor
- Universidade Federal de Mato Grosso
- Start
- Sep 2017
- Primary completion
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of isoniazid in Tuberculosis (TB), sponsored by Universidade Federal de Mato Grosso. Started Sep 2017; status: terminated.
02
Drugs
isoniazid
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on NCT03028129.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03028129.